ONDINE BIOMEDICAL LIMITED
Company number 10570442 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£33,667
Balance sheet as at 2025-12-31
What it does
The principal activity of the company is Research and experimental development on biotechnology
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-01-18
- Employees
- 1 (2025 accounts)
- Registered office
- Belfry House Champions Way, Hendon, London, United Kingdom, NW4 1PX
- Postcode
- NW4 1PX
- Capital
- 1,000 GBP
- Accounts category
- Total Exemption Full
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-01-17
- Next due by
- 2027-01-31
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 1 current · 1 resigned
Group structure
Controlled by Ondine Biomedical Inc. (BC0526736) — since 2021-12-06
From persons-with-significant-control filings on the public register.
Competitors London
This company ranks 38 among research and experimental development on biotechnology in London.
The class of 2017
37%
of the 435 companies in this sector incorporated in 2017 are still active today; 61% have since been dissolved.
A fact about the year, not a forecast for this company.